Table 5 Profiling of cytokines from the sera samples of PKDL, and VL patients, vs. healthy controls.
Sera profiling of | Healthy controls | PKDL patients | VL patients |
|---|---|---|---|
cytokines | (Mean ± SD) | (Mean ± SD) | (Mean ± SD) |
284.227 ± 236.144 | 327.024 ± 283.328 | ||
(n = 24) | (n = 11) | ||
IL-10 (pg/dL) | 274.245 ± 201.442 (n = 8) | Nodular (n = 8) 342.467 ± 201.571 | 328.811 ± 283.298 BT (n = 7) |
Macular (n = 16) | 293.095 ± 101.845 | ||
303.877 ± 232.059 | AT (n = 4) | ||
14.503 ± 14.927 | 12.757 ± 9.926 | ||
(n = 24) | (n = 11) | ||
IL-12 (ng/L) | 6.702 ± 2.738 (n = 7) | Nodular (n = 8) | 4.491 ± 2.265 |
15.127 ± 16.382 | BT (n = 7) | ||
Macular (n = 16) | 16.126 ± 3.66 | ||
14.195 ± 14.631 | AT (n = 4) | ||
5.238 5.693 | 4.028 ± 3.787 | ||
(n = 27) | (n = 13) | ||
IFNyR (ng/ml) | 3.641 ± 2.076 (n = 8) | Nodular(n = 10) 6.958 ± 3.419 | 2.043 ± 0.522 BT (n = 10) |
Macular (n = 17) | 9.808 ± 1.93 | ||
3.244 ± 2.125 | AT (n = 3) |
